CLINICAL_TRIALS
trial_result
· 2015-06-24
Clinical Trial Update: Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [Phase 2]
Summary
Phase 2 trial evaluating the combination of pamidronate and thalidomide in multiple myeloma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2015-06-24